Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Vertex Pharmaceutic (VRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 40,000,664
  • Shares Outstanding, K 254,830
  • Annual Sales, $ 2,489 M
  • Annual Income, $ 263,480 K
  • 36-Month Beta 1.44
  • Price/Sales 16.07
  • Price/Cash Flow 149.68
  • Price/Book 16.46

Price Performance

See More
Period Period Low Period High Performance
1-Month
145.78 +8.04%
on 05/03/18
160.85 -2.08%
on 04/26/18
+2.35 (+1.51%)
since 04/25/18
3-Month
145.78 +8.04%
on 05/03/18
178.25 -11.64%
on 03/13/18
-8.40 (-5.06%)
since 02/23/18
52-Week
118.05 +33.42%
on 05/26/17
178.25 -11.64%
on 03/13/18
+38.90 (+32.80%)
since 05/25/17

Most Recent Stories

More News
Is Genome Editing the Next Biotech Breakthrough?

Is Genome Editing the Next Biotech Breakthrough?

CRSP : 69.94 (+0.42%)
VRTX : 157.50 (+0.34%)
NVS : 76.10 (-0.09%)
EDIT : 36.53 (-0.27%)
REGN : 293.74 (-0.30%)
NTLA : 25.75 (-0.35%)
Is Genome Editing the Next Biotech Breakthrough?

Is Genome Editing the Next Biotech Breakthrough?

CRSP : 69.94 (+0.42%)
VRTX : 157.50 (+0.34%)
NVS : 76.10 (-0.09%)
EDIT : 36.53 (-0.27%)
REGN : 293.74 (-0.30%)
NTLA : 25.75 (-0.35%)
The Zacks Analyst Blog Highlights: General Dynamics, Enbridge, CSX, Humana and Vertex

The Zacks Analyst Blog Highlights: General Dynamics, Enbridge, CSX, Humana and Vertex

HUM : 294.41 (+0.25%)
VRTX : 157.50 (+0.34%)
ENB : 31.24 (-1.08%)
CSX : 64.68 (+0.39%)
GD : 208.12 (-0.29%)
Top Research Reports for General Dynamics, Enbridge & CSX Corporation

Top Research Reports for General Dynamics, Enbridge & CSX Corporation

BUD : 94.72 (-1.08%)
HUM : 294.41 (+0.25%)
VRTX : 157.50 (+0.34%)
ENB : 31.24 (-1.08%)
CSX : 64.68 (+0.39%)
GD : 208.12 (-0.29%)
Factors of Influence in 2018, Key Indicators and Opportunity within American Homes 4 Rent, Discovery Communications, Vertex Pharmaceuticals, The New York Times, Palatin Technologies, and E*TRADE Financial -- New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of American Homes 4 Rent (NYSE:AMH),...

DISCK : 20.95 (-1.37%)
VRTX : 157.50 (+0.34%)
NYT : 23.35 (+1.52%)
PTN : 1.16 (-1.69%)
AMH : 19.62 (-0.41%)
ETFC : 64.14 (-0.96%)
Biotech Stock Roundup: ALXN, VRTX Post Solid Results, GILD Disappoints in Q1

The biotech sector was in focus over the last five trading sessions as several bigwigs like Gilead and Vertex, among others reported results while some others provided pipeline updates.

VRTX : 157.50 (+0.34%)
GILD : 67.38 (-0.22%)
REGN : 293.74 (-0.30%)
AMGN : 178.24 (+0.16%)
ALXN : 117.74 (+0.51%)
BIIB : 286.21 (+0.63%)
Vertex Pharm Falls 1.08% on Heavy Volume: Watch For Potential Rebound

Vertex Pharm (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $150.40 to a high of $154.70. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $153.33...

VRTX : 157.50 (+0.34%)
Vertex Awards $400,000 in Scholarships to People Living with Cystic Fibrosis and Their Immediate Family Members

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the recipients of scholarships as part of its second All in for CF Scholarship program. Each of the 80 scholarship...

VRTX : 157.50 (+0.34%)
Vertex Pharm Falls 2.58% on Heavy Volume: Watch For Potential Rebound

Vertex Pharm (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $153.33 to a high of $159.05. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $154.13...

VRTX : 157.50 (+0.34%)
Look for Shares of Vertex Pharm to Potentially Rebound after Yesterday's 2.58% Sell Off

Vertex Pharm (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $153.33 to a high of $159.05. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $154.13...

VRTX : 157.50 (+0.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade VRTX with:

Business Summary

Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs...

See More

Key Turning Points

2nd Resistance Point 158.89
1st Resistance Point 158.19
Last Price 157.50
1st Support Level 156.51
2nd Support Level 155.53

See More

52-Week High 178.25
Last Price 157.50
Fibonacci 61.8% 155.25
Fibonacci 50% 148.15
Fibonacci 38.2% 141.05
52-Week Low 118.05

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar